In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids

The primary objective of this study was to investigate the aldose reductase inhibitory activity of flavonoids using in silico docking studies. In this perspective, flavonoids like biochanin, butein, esculatin, fisetin and herbacetin were selected. Epalrestat, a known aldose reductase inhibitor was u...

Full description

Bibliographic Details
Main Authors: Arumugam Madeswaran, Muthuswamy Umamaheswari, Kuppusamy Asokkumar, Thirumalaisamy Sivashanmugam, Varadharajan Subhadradevi, Puliyath Jagannath
Format: Article
Language:English
Published: Bangladesh Pharmacological Society 2012-11-01
Series:Bangladesh Journal of Pharmacology
Subjects:
Online Access:https://www.banglajol.info/index.php/BJP/article/view/12314
_version_ 1811317914119176192
author Arumugam Madeswaran
Muthuswamy Umamaheswari
Kuppusamy Asokkumar
Thirumalaisamy Sivashanmugam
Varadharajan Subhadradevi
Puliyath Jagannath
author_facet Arumugam Madeswaran
Muthuswamy Umamaheswari
Kuppusamy Asokkumar
Thirumalaisamy Sivashanmugam
Varadharajan Subhadradevi
Puliyath Jagannath
author_sort Arumugam Madeswaran
collection DOAJ
description The primary objective of this study was to investigate the aldose reductase inhibitory activity of flavonoids using in silico docking studies. In this perspective, flavonoids like biochanin, butein, esculatin, fisetin and herbacetin were selected. Epalrestat, a known aldose reductase inhibitor was used as the standard. In silico docking studies were carried out using AutoDock 4.2, based on the Lamarckian genetic algorithm principle. The results showed that all the selected flavonoids showed binding energy ranging between -9.33 kcal/mol to -7.23 kcal/mol when compared with that of the standard (-8.73 kcal/mol). Inhibition constant (144.13 µM to 4.98 µM) and intermolecular energy (-11.42 kcal/mol to -7.83 kcal/mol) of the flavonoids also coincide with the binding energy. All the selected flavonoids contributed aldose reductase inhibitory activity because of its structural properties. These molecular docking analyses could lead to the further development of potent aldose reductase inhibitors for the treatment of diabetes.
first_indexed 2024-04-13T12:16:40Z
format Article
id doaj.art-e838b32d0956481a813750a517323d56
institution Directory Open Access Journal
issn 1991-0088
language English
last_indexed 2024-04-13T12:16:40Z
publishDate 2012-11-01
publisher Bangladesh Pharmacological Society
record_format Article
series Bangladesh Journal of Pharmacology
spelling doaj.art-e838b32d0956481a813750a517323d562022-12-22T02:47:20ZengBangladesh Pharmacological SocietyBangladesh Journal of Pharmacology1991-00882012-11-017410.3329/bjp.v7i4.12314In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoidsArumugam Madeswaran0Muthuswamy Umamaheswari1Kuppusamy Asokkumar2Thirumalaisamy Sivashanmugam3Varadharajan Subhadradevi4Puliyath Jagannath5Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil NaduDepartment of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil NaduDepartment of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil NaduDepartment of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil NaduDepartment of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil NaduDepartment of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil NaduThe primary objective of this study was to investigate the aldose reductase inhibitory activity of flavonoids using in silico docking studies. In this perspective, flavonoids like biochanin, butein, esculatin, fisetin and herbacetin were selected. Epalrestat, a known aldose reductase inhibitor was used as the standard. In silico docking studies were carried out using AutoDock 4.2, based on the Lamarckian genetic algorithm principle. The results showed that all the selected flavonoids showed binding energy ranging between -9.33 kcal/mol to -7.23 kcal/mol when compared with that of the standard (-8.73 kcal/mol). Inhibition constant (144.13 µM to 4.98 µM) and intermolecular energy (-11.42 kcal/mol to -7.83 kcal/mol) of the flavonoids also coincide with the binding energy. All the selected flavonoids contributed aldose reductase inhibitory activity because of its structural properties. These molecular docking analyses could lead to the further development of potent aldose reductase inhibitors for the treatment of diabetes.https://www.banglajol.info/index.php/BJP/article/view/12314Binding energyInhibition constantIntermolecular energyLigands
spellingShingle Arumugam Madeswaran
Muthuswamy Umamaheswari
Kuppusamy Asokkumar
Thirumalaisamy Sivashanmugam
Varadharajan Subhadradevi
Puliyath Jagannath
In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
Bangladesh Journal of Pharmacology
Binding energy
Inhibition constant
Intermolecular energy
Ligands
title In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
title_full In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
title_fullStr In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
title_full_unstemmed In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
title_short In silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
title_sort in silico docking studies of aldose reductase inhibitory activity of commercially available flavonoids
topic Binding energy
Inhibition constant
Intermolecular energy
Ligands
url https://www.banglajol.info/index.php/BJP/article/view/12314
work_keys_str_mv AT arumugammadeswaran insilicodockingstudiesofaldosereductaseinhibitoryactivityofcommerciallyavailableflavonoids
AT muthuswamyumamaheswari insilicodockingstudiesofaldosereductaseinhibitoryactivityofcommerciallyavailableflavonoids
AT kuppusamyasokkumar insilicodockingstudiesofaldosereductaseinhibitoryactivityofcommerciallyavailableflavonoids
AT thirumalaisamysivashanmugam insilicodockingstudiesofaldosereductaseinhibitoryactivityofcommerciallyavailableflavonoids
AT varadharajansubhadradevi insilicodockingstudiesofaldosereductaseinhibitoryactivityofcommerciallyavailableflavonoids
AT puliyathjagannath insilicodockingstudiesofaldosereductaseinhibitoryactivityofcommerciallyavailableflavonoids